The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARα and overcomes ATRA resistance in acute promyelocytic leukemia cells
- Resource Type
- Article
- Source
- In
Biochemical Pharmacology August 2023 214 - Subject
- Language
- ISSN
- 0006-2952